Glenmark Pharma Shares Surge 10% on AbbVie Cancer Deal
Glenmark Pharmaceuticals saw its share price hit the 10% upper circuit after announcing a major cancer drug licensing agreement with AbbVie. The deal has sparked bullish analyst sentiment, projecting strong...
